Jun Ling
Taiyuan, 030001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Artificial intelligence-driven discovery of YH395A: A novel TGFβR1 inhibitor with potent anti-tumor activity against triple-negative breast cancer.
Journal: Cell communication and signaling : CCS
Published: February 21, 2025
Effects of SB939 are mediated by STAT3 to inhibit breast cancer cell metastasis-related genes.
Journal: Oncology letters
Published: September 25, 2024
Discovery of YH677 as a cancer stemness inhibitor that suppresses triple-negative breast cancer growth and metastasis by regulating the TGFβ signaling pathway.
Journal: Cancer letters
Published: December 19, 2022
A Regulatory Network Analysis of the Importance of USP15 in Breast Cancer Metastasis and Prognosis.
Journal: Journal of oncology
Published: July 06, 2022
Limonin inhibits angiogenesis and metastasis of human breast cancer cells by suppressing the VEGFR2/IGFR1-mediated STAT3 signaling pathway.
Journal: Translational cancer research
Published: May 04, 2020
Narasin inhibits tumor metastasis and growth of ERα‑positive breast cancer cells by inactivation of the TGF‑β/SMAD3 and IL‑6/STAT3 signaling pathways.
Journal: Molecular medicine reports
Published: December 27, 2019
Pracinostat (SB939), a histone deacetylase inhibitor, suppresses breast cancer metastasis and growth by inactivating the IL-6/STAT3 signalling pathways.
Journal: Life sciences
Published: November 27, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026